CardioFocus explored visually guided laser ablation in recent clinical research as a single-centre long-term experience. The researched revealed single-centre experience incorporating VGLA over four years can be safely applied in clinical practice with effective results. The research demonstrated high levels of acute PVI together with positive, long-term clinical outcomes.
The study was conducted with one hundred and ninety-four patients who suffered a medical history of drug-refractory PAF or recurrent AF. CardioFocus administered treatment in their laboratory with VGLA between over the course of four years. The single-center VGLA treatment demonstrated high levels of effectivity.